The overexpressed miR-429 in breast cancers with amplified human epidermal growth factor receptor 2 (HER2+) was responsible for the increased proliferation and migration of breast cancer cells, while the silencing of miR-429 had an impact on tumor growth postponement [147]. Here, ERBB2 is linked to breast cancer.